Literature DB >> 1431957

Thalamocortical diaschisis: positron emission tomography in humans.

J C Baron1, M Levasseur, B Mazoyer, F Legault-Demare, F Mauguière, S Pappata, P Jedynak, P Derome, J Cambier, S Tran-Dinh.   

Abstract

To investigate further the relations between cortical energy metabolism and neuropsychological impairment after unilateral thalamic lesion, 55 patients underwent positron emission tomography studies of either cortical oxygen consumption or glucose utilisation, including eight repeat studies, at times ranging from 4 days to 98 months after the onset of the lesion [stroke (n = 44) or stereotaxic VL-Vim thalamotomy performed for movement disorders (n = 11)]. Patients with thalamotomy were also studied preoperatively and the surgery induced a significant fall in cortical metabolism on both sides (more so ipsilaterally); post-operatively the magnitude of the ipsilateral cortex hypometabolism was positively correlated to the severity of global neuropsychological impairment; similar but less significant findings were obtained for the ipsilateral/contralateral cortical metabolic asymmetry. With respect to the whole patient sample, the cortical metabolic asymmetry was initially pronounced, with subsequent monoexponential recovery, in the cognitively impaired study group, but it was only mild and showed no meaningful trend for recovery in the cognitively unaffected study group; yet even soon (< 3 months) after thalamic lesion there was a noticeable overlap of individual asymmetry values among the two study groups. These results lend further support to the view that the neuropsychological impairment that frequently follows unilateral thalamic lesions is reflected in a depression of synaptic activity in both the overlying and the contralateral cerebral cortices. For individual patients, this study also illustrates the potentially misleading nature of the measured cortical metabolic asymmetry with respect to neuropsychological status, especially at late times after lesion, in part because side to side metabolic ratios do not reflect bilateral changes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1431957      PMCID: PMC1015196          DOI: 10.1136/jnnp.55.10.935

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  32 in total

Review 1.  Large-scale neurocognitive networks and distributed processing for attention, language, and memory.

Authors:  M M Mesulam
Journal:  Ann Neurol       Date:  1990-11       Impact factor: 10.422

2.  Brain energy metabolism in bilateral paramedian thalamic infarcts. A positron emission tomography study.

Authors:  M Levasseur; J C Baron; G Sette; F Legault-Demare; S Pappata; F Mauguière; N Benoit; S Tran Dinh; J D Degos; D Laplane
Journal:  Brain       Date:  1992-06       Impact factor: 13.501

3.  [Correlation of thalamic aphasia and cerebral blood flow].

Authors:  M Rousseaux; M Steinling; G Griffié; S Quint; M Cabaret; F Lesoin; M Mazingue; A Destée
Journal:  Rev Neurol (Paris)       Date:  1990       Impact factor: 2.607

4.  Effects of capsular or thalamic stroke on metabolism in the cortex and cerebellum: a positron tomography study.

Authors:  S Pappata; B Mazoyer; S Tran Dinh; H Cambon; M Levasseur; J C Baron
Journal:  Stroke       Date:  1990-04       Impact factor: 7.914

5.  Effects of anterior corpus callosum section on cortical glucose utilization in baboons. A sequential positron emission tomography study.

Authors:  T Yamaguchi; M Kunimoto; S Pappata; C Chavoix; D Riche; L Chevalier; B Mazoyer; M Mazière; R Naquet; J C Baron
Journal:  Brain       Date:  1990-08       Impact factor: 13.501

6.  Effects of unilateral lesion of the nucleus basalis of Meynert on brain glucose utilization in callosotomized baboons: a PET study.

Authors:  T Yamaguchi; M Kunimoto; S Pappata; C Chavoix; E Brouillet; D Riche; M Mazière; R Naquet; E T MacKenzie; J C Baron
Journal:  J Cereb Blood Flow Metab       Date:  1990-09       Impact factor: 6.200

7.  Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: validation of method.

Authors:  M E Phelps; S C Huang; E J Hoffman; C Selin; L Sokoloff; D E Kuhl
Journal:  Ann Neurol       Date:  1979-11       Impact factor: 10.422

8.  Positron emission tomography study in progressive supranuclear palsy. Brain hypometabolic pattern and clinicometabolic correlations.

Authors:  J Blin; J C Baron; B Dubois; B Pillon; H Cambon; J Cambier; Y Agid
Journal:  Arch Neurol       Date:  1990-07

9.  Quantitative measurement of regional cerebral blood flow and oxygen metabolism in man using 15O and positron emission tomography: theory, procedure, and normal values.

Authors:  R S Frackowiak; G L Lenzi; T Jones; J D Heather
Journal:  J Comput Assist Tomogr       Date:  1980-12       Impact factor: 1.826

10.  Computer-assisted stereotactic ventralis lateralis thalamotomy with microelectrode recording control in patients with Parkinson's disease.

Authors:  P J Kelly; J E Ahlskog; S J Goerss; J R Daube; J R Duffy; B A Kall
Journal:  Mayo Clin Proc       Date:  1987-08       Impact factor: 7.616

View more
  26 in total

Review 1.  Unraveling the contributions of the diencephalon to recognition memory: a review.

Authors:  John P Aggleton; Julie R Dumont; Elizabeth Clea Warburton
Journal:  Learn Mem       Date:  2011-05-19       Impact factor: 2.460

2.  99mTc-ECD brain perfusion SPECT imaging for the assessment of brain perfusion in cerebral palsy (CP) patients with evaluation of the effect of hyperbaric oxygen therapy.

Authors:  Mina Taghizadeh Asl; Farzaneh Yousefi; Reza Nemati; Majid Assadi
Journal:  Int J Clin Exp Med       Date:  2015-01-15

3.  Diagnostic manifestations of total hemispheric glucose metabolism ratio in neuronal network diaschisis: diagnostic implications in Alzheimer's disease and mild cognitive impairment.

Authors:  Eivind A Segtnan; Alireza Majdi; Caius Constantinescu; Peter Grupe; Oke Gerke; Heini Í Dali; Olaf Emil Strøm; Jorun Holm; Abass Alavi; Saeed Sadigh-Eteghad; Lene Wermuth; Malene G Hildebrandt; Albert Gjedde; Poul Flemming Høilund-Carlsen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-01-12       Impact factor: 9.236

4.  "Thalamic aphasia" after stroke is associated with left anterior lesion location.

Authors:  Merve Fritsch; Thomas Krause; Fabian Klostermann; Kersten Villringer; Manuela Ihrke; Christian H Nolte
Journal:  J Neurol       Date:  2019-09-27       Impact factor: 4.849

5.  Disorders of higher mental function due to single infarctions in the thalamus and in the area of the thalamofrontal tracts.

Authors:  L A Kalashnikova; T S Gulevskaya; E M Kashina
Journal:  Neurosci Behav Physiol       Date:  1999 Jul-Aug

6.  Crossed Cerebellar Diaschisis in Alzheimer's Disease Detected by Arterial Spin-labelling Perfusion MRI.

Authors:  Alexander Hertel; Holger Wenz; Mansour Al-Zghloul; Lucrezia Hausner; Lutz FrÖlich; Christoph Groden; Alex FÖrster
Journal:  In Vivo       Date:  2021 Mar-Apr       Impact factor: 2.155

7.  Persistent pure verbal amnesia and transient aphasia after left thalamic infarction.

Authors:  N Sodeyama; M Tamaki; M Sugishita
Journal:  J Neurol       Date:  1995-05       Impact factor: 4.849

8.  Neuropsychological correlates of a right unilateral lacunar thalamic infarction.

Authors:  Y D Van Der Werf; J G Weerts; J Jolles; M P Witter; J Lindeboom; P Scheltens
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-01       Impact factor: 10.154

9.  Cerebral glucose metabolism in long-term survivors of childhood primary brain tumors treated with surgery and radiotherapy.

Authors:  Preben B Andersen; Katja Krabbe; Anne M Leffers; Marianne Schmiegelow; Søren Holm; Henning Laursen; Jørn R Müller; Olaf B Paulson
Journal:  J Neurooncol       Date:  2003-05       Impact factor: 4.130

10.  Perfusion imaging in Pusher syndrome to investigate the neural substrates involved in controlling upright body position.

Authors:  Luca Francesco Ticini; Uwe Klose; Thomas Nägele; Hans-Otto Karnath
Journal:  PLoS One       Date:  2009-05-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.